ClinicalTrials.gov

History of Changes for Study: NCT04368728
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
Latest version (submitted July 21, 2021) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 April 29, 2020 None (earliest Version on record)
2 May 4, 2020 Recruitment Status, Study Status, Study Design, References, Contacts/Locations and Oversight
3 May 5, 2020 Study Design and Study Status
4 May 13, 2020 Study Status and Contacts/Locations
5 June 4, 2020 Study Status, Contacts/Locations, Study Design and Study Identification
6 June 26, 2020 Contacts/Locations, Study Design and Study Status
7 July 15, 2020 Recruitment Status, Arms and Interventions, Outcome Measures, Study Status, Contacts/Locations, Eligibility, Study Design, Study Description and Study Identification
8 July 21, 2020 Contacts/Locations, Study Design, Study Status and Study Identification
9 July 27, 2020 IPDSharing, References, Contacts/Locations, Study Design, Study Status and Study Identification
10 July 30, 2020 Recruitment Status, Study Status and Contacts/Locations
11 July 31, 2020 Arms and Interventions, Outcome Measures, Study Status, References, Contacts/Locations, Eligibility, Study Design and Study Description
12 August 6, 2020 Contacts/Locations and Study Status
13 August 17, 2020 Contacts/Locations and Study Status
14 September 3, 2020 Contacts/Locations and Study Status
15 September 25, 2020 Contacts/Locations, Eligibility, Study Status, Arms and Interventions, Study Identification, Study Design and Study Description
16 October 14, 2020 Contacts/Locations, Study Status and Eligibility
17 October 23, 2020 Outcome Measures, Contacts/Locations, Arms and Interventions, Eligibility, Study Description and Study Status
18 October 30, 2020 Contacts/Locations and Study Status
19 November 11, 2020 Study Status, Contacts/Locations and Outcome Measures
20 November 20, 2020 Study Status and Contacts/Locations
21 December 15, 2020 Study Status and Contacts/Locations
22 December 22, 2020 Arms and Interventions, Study Description and Study Status
23 January 8, 2021 Study Status, Contacts/Locations and Study Design
24 January 20, 2021 Recruitment Status, Study Status, Contacts/Locations, Outcome Measures and Study Design
25 February 9, 2021 Study Status
26 March 17, 2021 Contacts/Locations, Arms and Interventions, Study Status and Study Description
27 March 30, 2021 Contacts/Locations, Arms and Interventions, Study Status, Outcome Measures, Eligibility and Study Description
28 April 9, 2021 Recruitment Status, Study Status and Contacts/Locations
29 April 29, 2021 Arms and Interventions, Outcome Measures, Contacts/Locations, Eligibility, Study Design, Study Description and Study Status
30 May 28, 2021 Study Status, Contacts/Locations and Study Design
31 July 21, 2021 Study Status, Contacts/Locations and Eligibility
Comparison Format:

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services